High water content BSA-PEG hydrogel for controlled release device: Evaluation of the drug release properties

Journal of Controlled Release

Volumn 38, Issue 2-3, 1996, Pages 177-184

  Gayet, J C ^a   Fortier, G ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Albumin; Controlled release; Diffusion; Hydrogel; Poly(ethylene glycol)

Indexed keywords

BOVINE SERUM ALBUMIN; COPOLYMER; CORTISONE; HYDROCORTISONE; LYSOZYME; MACROGOL; METHYLENE BLUE; PARACETAMOL; PREDNISONE; TETRACYCLINE; THEOPHYLLINE; WATER;

ARTICLE; CONTROLLED STUDY; DIFFUSION; DRUG RELEASE; HALF LIFE TIME; HYDROGEL; MOLECULAR WEIGHT; PHARMACEUTICS; POLYMERIZATION; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

EID: 0029873089     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(95)00118-2     Document Type: Article

References (14)

1. N.A. Peppas, Hydrogels in Medicine and Pharmacy, Vol. 1-3, CRC Press, Boca Raton, FL, 1987.
2. R. Baker, Controlled Release of Biologically Active Agents, John Wiley and Sons, New York, 1987.
3. P.I. Lee, Synthetic hydrogels for drug delivery: Preparation, characterization, and release kinetics, in: D. Hsieh (Ed.), Controlled Release Systems: Fabrication Technology, Vol. 2, CRC Press, Boca Raton, FL, 1988, pp. 61-82.
4. A.S. Fox, J.R. Crison, S.Y. Lin and G.L. Amidon, PVP-based hydrogels for controlled drug delivery, Proc. Int. Symp. Control. Release Bioact. Mater. 21 (1994) 481-482.
5. E.M. D'Urso and G. Fortier, New hydrogel based on polyethylene glycol cross-linked with bovine serum albumin, Biotechnol. Techn. 8 (1994) 71-76.
6. E.M. D'Urso and G. Fortier, New bioartificial polymeric material: Poly(ethylene glycol) cross-linked with albumin. I. Synthesis and swelling properties. J. Bioact. Comp. Polym. 9 (1994) 367-387.
7. P. Gusti, L. Lazzari and L. Lelli, Bioartificials polymeric materials: A new method to design biomaterials by using both biological and synthetic polymers. Trends Polym. Sci. 9 (1993) 261-267.
8. M. Amiji and K. Park, Surface modification of polymeric biomaterials with poly(ethylene oxide), albumin, and heparin for reduced thrombogenicity, J. Biomater. Sci. Polym. Edn 4 (1993) 217-234.
9. G.R. Llanos and M.V. Sefton, Review. Does polyethylene oxide possess alow thrombogenicity?, J. Biomater. Sci. Polym. Edn 4 (1993) 381-400.
10. F.F. Davis, A. Abuchowski, T. van Es, N.C. Palczuk, K. Sacova, R.H.-L. Chen and P. Pyatak, Soluble, nonantigenic polyethylene glycol-bound enzymes, in: E.P. Goldberg and A. Nakajima (Eds), Biomedical Polymers: Polymeric Materials and Pharmaceuticals for Biomedical Use, Academic Press, New York, 1980, pp. 441-452.
11. A. Abuchowski and F.F. Davis, Soluble polymer-enzyme adducts, in: J.S. Holcenberg and J. Roberts (Eds), Enzymes as Drugs, John Wiley & Sons, New York, 1981, pp. 367-383.
12. G. Fortier and M. Laliberté, Surface modification of horseradish peroxidase with poly(ethylene glycol)s of various molecular masses, Biotechnol. Appl. Biochem. 17 (1993) 115-130.
13. R.W. Korsmeyer and N.A. Peppas, Effect of the morphology of hydrophilic polymeric matrices on the diffusion and release of water soluble drugs, J. Membr. Sci. 9 (1981) 211-227.
14. I. Jalal, E. Zmaily and N. Najib, Dissolution kinetics of commercially available controlled-release theophylline preparations, Int. J. Pharm. 52 (1989) 63-70.